Adiponectin Agonist ADP355 Attenuates CCl4-Induced Liver Fibrosis in Mice

Open Access

Peer-reviewed

Research Article

Adiponectin Agonist ADP355 Attenuates CCl₄-Induced Liver Fibrosis in Mice

Pradeep Kumar,

Affiliation Emory University School of Medicine, Department of Medicine, Division of Digestive Diseases, Atlanta, GA, United States of America
⨯
Tekla Smith,

Affiliation Emory University School of Medicine, Department of Medicine, Division of Digestive Diseases, Atlanta, GA, United States of America
⨯
Khalidur Rahman,

Affiliation Emory University School of Medicine, Department of Medicine, Division of Digestive Diseases, Atlanta, GA, United States of America
⨯
Natalie E. Thorn,

Affiliation Emory University School of Medicine, Department of Medicine, Division of Digestive Diseases, Atlanta, GA, United States of America
⨯
Frank A. Anania

* E-mail: fanania@emory.edu

Affiliation Emory University School of Medicine, Department of Medicine, Division of Digestive Diseases, Atlanta, GA, United States of America
⨯

Nanoparticles
Is the Subject Area "Nanoparticles" applicable to this article?

Thanks for your feedback.
Liver fibrosis
Is the Subject Area "Liver fibrosis" applicable to this article?

Thanks for your feedback.
Collagens
Is the Subject Area "Collagens" applicable to this article?

Thanks for your feedback.
Adiponectin
Is the Subject Area "Adiponectin" applicable to this article?

Thanks for your feedback.
Fatty liver
Is the Subject Area "Fatty liver" applicable to this article?

Thanks for your feedback.
Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.